FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320498889> ?p ?o ?g. }

• W4320498889 endingPage "111815" @default.
• W4320498889 startingPage "111815" @default.
• W4320498889 abstract "PARP inhibitors inflict severe toxicity to homologous recombination (HR) repair deficient cells because DNA damages induced by PARP inhibition result in lethal DNA double strand breaks in the absence of HR repair during DNA replication. PARP inhibitors are the first clinically approved drugs designed for synthetic lethality. The synthetic lethal interaction of PARP inhibitors is not limited to HR repair deficient cells. We investigated radiosensitive mutants isolated from Chinese hamster lung origin V79 cells to identify novel synthetic lethal targets in the context of PARP inhibition. HR repair deficient BRCA2 mutant cells were used for positive control. Among tested cells, XRCC8 mutants presented hypersensitivity to PARP inhibitor, Olaparib. XRCC8 mutants showed elevated sensitivity to bleomycin and camptothecin similar to BRCA2 mutants. XRCC8 mutants presented an elevation of γ-H2AX foci formation frequency and S-phase dependent chromosome aberrations with Olaparib treatment. Enumerated damage foci following Olaparib treatment were observed to be elevated in XRCC8 as in BRCA2 mutants. Although this may suggest that XRCC8 plays a role in a similar DNA repair pathway as BRCA2 in HR repair, XRCC8 mutants presented functional HR repair including proper Rad51 foci formation and even elevated sister chromatid exchange frequencies with PARP inhibitor treatment. For comparison, RAD51 foci formation was suppressed in HR repair deficient BRCA2 mutants. Additionally, XRCC8 mutants did not display delayed mitotic entry with PARP inhibitors whereas BRCA2 mutants did. XRCC8 mutant cell line has previously been reported as possessing a mutation in the ATM gene. XRCC8 mutants displayed maximum cytotoxicity to ATM inhibitor among tested mutants and wild type cells. Furthermore, the ATM inhibitor sensitized XRCC8 mutant to ionzing radiation, however, XRCC8 mutant V-G8 expressed reduced levels of ATM protein. The gene responsible for XRCC8 phenotype may not be ATM but highly associated with ATM functions. These results suggest that XRCC8 mutation is a target for PARP inhibitor-induced synthetic lethality in HR repair independent manner via the disruption of cell cycle regulation. Our findings expand the potential application of PARP inhibitors in tumors lacking DNA damage responding genes other than HR repair, and further investigation of XRCC8 may contribute to this research." @default.
• W4320498889 created "2023-02-14" @default.
• W4320498889 creator A5000770470 @default.
• W4320498889 creator A5010220365 @default.
• W4320498889 creator A5041338128 @default.
• W4320498889 date "2023-01-01" @default.
• W4320498889 modified "2023-10-17" @default.
• W4320498889 title "XRCC8 mutation causes hypersensitivity to PARP inhibition without Homologous recombination repair deficiency" @default.
• W4320498889 cites W1969458729 @default.
• W4320498889 cites W1987345634 @default.
• W4320498889 cites W1994147983 @default.
• W4320498889 cites W1998869208 @default.
• W4320498889 cites W2004789696 @default.
• W4320498889 cites W2009007206 @default.
• W4320498889 cites W2012414948 @default.
• W4320498889 cites W2017074215 @default.
• W4320498889 cites W2022529631 @default.
• W4320498889 cites W2025726479 @default.
• W4320498889 cites W2040246945 @default.
• W4320498889 cites W2045079126 @default.
• W4320498889 cites W2046463062 @default.
• W4320498889 cites W2054202007 @default.
• W4320498889 cites W2098858031 @default.
• W4320498889 cites W2101988823 @default.
• W4320498889 cites W2103272211 @default.
• W4320498889 cites W2103272465 @default.
• W4320498889 cites W2116005493 @default.
• W4320498889 cites W2116678138 @default.
• W4320498889 cites W2117459346 @default.
• W4320498889 cites W2118211359 @default.
• W4320498889 cites W2142658272 @default.
• W4320498889 cites W2147126714 @default.
• W4320498889 cites W2149967415 @default.
• W4320498889 cites W2150587707 @default.
• W4320498889 cites W2162157249 @default.
• W4320498889 cites W2178647298 @default.
• W4320498889 cites W2180683470 @default.
• W4320498889 cites W2526969304 @default.
• W4320498889 cites W2549069008 @default.
• W4320498889 cites W2728023387 @default.
• W4320498889 cites W2896578193 @default.
• W4320498889 cites W2916021243 @default.
• W4320498889 cites W2942592255 @default.
• W4320498889 cites W2944804758 @default.
• W4320498889 cites W2951114010 @default.
• W4320498889 cites W2979841690 @default.
• W4320498889 cites W3083872056 @default.
• W4320498889 cites W3084114043 @default.
• W4320498889 cites W3207665029 @default.
• W4320498889 cites W4298690306 @default.
• W4320498889 doi "https://doi.org/10.1016/j.mrfmmm.2023.111815" @default.
• W4320498889 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36812659" @default.
• W4320498889 hasPublicationYear "2023" @default.
• W4320498889 type Work @default.
• W4320498889 citedByCount "0" @default.
• W4320498889 crossrefType "journal-article" @default.
• W4320498889 hasAuthorship W4320498889A5000770470 @default.
• W4320498889 hasAuthorship W4320498889A5010220365 @default.
• W4320498889 hasAuthorship W4320498889A5041338128 @default.
• W4320498889 hasConcept C102744134 @default.
• W4320498889 hasConcept C104317684 @default.
• W4320498889 hasConcept C104451858 @default.
• W4320498889 hasConcept C134935766 @default.
• W4320498889 hasConcept C143065580 @default.
• W4320498889 hasConcept C143425029 @default.
• W4320498889 hasConcept C153911025 @default.
• W4320498889 hasConcept C182979987 @default.
• W4320498889 hasConcept C23458808 @default.
• W4320498889 hasConcept C2778502085 @default.
• W4320498889 hasConcept C2779012473 @default.
• W4320498889 hasConcept C2779138821 @default.
• W4320498889 hasConcept C2779962180 @default.
• W4320498889 hasConcept C501734568 @default.
• W4320498889 hasConcept C54355233 @default.
• W4320498889 hasConcept C552990157 @default.
• W4320498889 hasConcept C82381507 @default.
• W4320498889 hasConcept C86803240 @default.
• W4320498889 hasConceptScore W4320498889C102744134 @default.
• W4320498889 hasConceptScore W4320498889C104317684 @default.
• W4320498889 hasConceptScore W4320498889C104451858 @default.
• W4320498889 hasConceptScore W4320498889C134935766 @default.
• W4320498889 hasConceptScore W4320498889C143065580 @default.
• W4320498889 hasConceptScore W4320498889C143425029 @default.
• W4320498889 hasConceptScore W4320498889C153911025 @default.
• W4320498889 hasConceptScore W4320498889C182979987 @default.
• W4320498889 hasConceptScore W4320498889C23458808 @default.
• W4320498889 hasConceptScore W4320498889C2778502085 @default.
• W4320498889 hasConceptScore W4320498889C2779012473 @default.
• W4320498889 hasConceptScore W4320498889C2779138821 @default.
• W4320498889 hasConceptScore W4320498889C2779962180 @default.
• W4320498889 hasConceptScore W4320498889C501734568 @default.
• W4320498889 hasConceptScore W4320498889C54355233 @default.
• W4320498889 hasConceptScore W4320498889C552990157 @default.
• W4320498889 hasConceptScore W4320498889C82381507 @default.
• W4320498889 hasConceptScore W4320498889C86803240 @default.
• W4320498889 hasLocation W43204988891 @default.
• W4320498889 hasLocation W43204988892 @default.
• W4320498889 hasOpenAccess W4320498889 @default.

• next